Stockreport

MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024 [Yahoo! Finance]

Tango Therapeutics, Inc.  (TNGX) 
PDF with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January – March Financial summary for the qu [Read more]